“…In our previous study, the supernatant obtained from the L. brevis KT16-2 strain was found to have a broader antimicrobial activity spectrum, including activity against M-R S. epidermidis and M&V-R S. warneri ( Kunduhoglu and Hacioglu, 2021 ). Silva et al (2019) determined that the L. brevis A6, B16 and E35 strains produce bacteriocin-like antimicrobial peptides against Escherichia coli , Enterococcus faecalis , L. monocytogenes, Salmonella Tyhimurium and Shigella flexneri . However, Fonseca et al (2021) reported that the L. brevis CCMA 1284 strain had no antimicrobial effect on any indicator test bacteria such as E. coli CDC 055, B. cereus ATCC 14579, S. aureus ATCC 5674 and L. monocytogenes ATCC 19117.…”